Ornithine Transcarbamylase deficiency
-
Plymouth Meeting Firm Tests Liver Disease Gene Therapy; Trials Target the Condition in Babies
A gene-therapy regimen designed to treat liver disease is being tested on babies at iECURE, a Plymouth Meeting-based biopharma company.…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
